FBLG
FibroBiologics, Inc. Common Stock
NASDAQ · Healthcare · Biotechnology · US
$1.81
+2.84%Next report
Analyst consensus
- Next report date
- Oct 30, 2026
- EPS estimate
- -$0.63
- Revenue estimate
- —
Latest reported
- Last report date
- Jul 31, 2026
- EPS actual
- -$0.66
- EPS estimate
- -$0.93
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 3
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +15.0%
- Revenue beats (12Q)
- —
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Oct 30, 2026